AzTrials
AzTrials

EmergencyNCT02297113

Rapid Sequence Intubation at the Emergency Department

A study testing Macintosh blade and C-MAC videolaryngoscope in people with Emergency, run by University of Zurich at 1 site in Switzerland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

All patients undergoing emergent endotracheal intubation (RSI) at the Emergency Department will be screened for inclusion in this clinical study. The indication of endotracheal intubation is an exclusively clinical decision and is not affected by this study protocol in any aspect. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Emergency
What is being tested?
Macintosh blade and C-MAC videolaryngoscope
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
150 participants
Where
1 siteSwitzerland
Study dates
Nov 2014to Dec 2015
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients requiring emergency Rapid Sequence Intubation at the emergency department
  • Male and Female subjects 18 years to 99 years of age
  • Written confirmation by a physician not involved in this study
  • Written informed consent by the participant (obtained afterwards)
  • Patient not showing remarkable rejection in participation in this study

Who cannot join

  • Maxilla-Facial trauma
  • Immobilized cervical spine
  • Indication for fiberoptic guided intubation (known difficult airway)
  • Ongoing Cardio-Pulmonary-Resuscitation (CPR)
  • Involvement in any other clinical trial during the course of this trial, within a period of 30 days prior to its beginning or 30 days after its completion
  • Severe or immediately life-treating injury requiring immediate medical treatment

Trial locations and contacts

1 site in 1 country.

Switzerland1 site
  • University Hospital Zuerich, Dept of Anesthesiology

    Zurich, Canton of Zurich, 8091

Other trials in Switzerland

About this study

Official title: The C-MAC Videolaryngoscope Compared With Conventional Laryngoscopy for Rapid Sequence Intubation at the Emergency Department

All patients undergoing emergent endotracheal intubation (RSI) at the Emergency Department will be screened for inclusion in this clinical study. The indication of endotracheal intubation is an exclusively clinical decision and is not affected by this study protocol in any aspect.

If fulfilling the In- and exclusion criteria's, patient will be randomly assigned to one of two groups

  1. C-MAC Videolaryngoscope in appropriate size
  2. conventional endotracheal intubation using Macintosh Blade in appropriate size

Randomization (1:1) will be based on computer-generated codes maintained in sequentially numbered opaque envelopes that will be opened immediately before randomization.

Conditions
Emergency
Being tested
Macintosh blade, C-MAC videolaryngoscope
Keywords
patients, departement, requiring Rapid Sequence Intubation (RSI)
Medical subject headings
Emergencies

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Macintosh bladeDevice

    conventional endotracheal intubation

  • C-MAC videolaryngoscopeDevice

Study groups in NCT02297113
Study groupRoleWhat they receive
conventional endotracheal intubationActive comparatorPatients assigned to this group will be intubated using conventional Macintosh blade in adequate size.
Receives: Device: Macintosh blade
C-MACActive comparatorPatients assigned to this group will be intubated using C-MAC videolaryngoscope in adequate size.
Receives: Device: C-MAC videolaryngoscope

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Success Rate

    defined as successful placement of endotracheal tube within the trachea and

    Measured: 10 minutes

Secondary outcomes (8)
  1. time to intubation

    defined as time between insertion of the videolaryngoscope/ Macintosh blade into the mouth until detection of end-tidal CO2

    Measured: 10 minutes

  2. Laryngoscopic view

    Cormack and Lehane Score

    Measured: 10 minutes

  3. Number of intubation attempts

    Measured: 10 minutes

  4. Unrecognized esophageal intubation

    Measured: 10 minutes

  5. Ease of intubation (1-5)

    • (1) very easy, (2) easy, (3) somewhat difficult, (4) difficult, (5) impossible

    Measured: 10 minutes

  6. Violations of the teeth

    number of patients; teeth will be inspected for potential damage and documented accordingly

    Measured: 10 minutes

  7. Necessity of using further, alternative airway devices for successful intubation (if randomized airway device failed)

    number of patients, requiring alternate device

    Measured: 10 minutes

  8. Maximum drop of saturation

    Spo2 will be measured continuously and documented accordingly

    Measured: 10 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Nov 2014 (estimated)
  2. Study startNov 2014
  3. Primary completionDec 2015
  4. Study completionDec 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
150 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02297113
Sponsor's protocol ID
KEK Zurich 2014-0356
Status last verified
Mar 2016
First submitted
13 Nov 2014
Last updated
25 Mar 2016
Results posted
No
Data monitoring committee
No

Publications

  • Sulser S, Ubmann D, Brueesch M, Goliasch G, Seifert B, Spahn DR, Ruetzler K. The C-MAC videolaryngoscope compared with conventional laryngoscopy for rapid sequence intubation at the emergency department: study protocol. Scand J Trauma Resusc Emerg Med. 2015 Apr 24;23:38. doi: 10.1186/s13049-015-0119-x.

    PubMed 25903358
  • Sulser S, Ubmann D, Schlaepfer M, Brueesch M, Goliasch G, Seifert B, Spahn DR, Ruetzler K. C-MAC videolaryngoscope compared with direct laryngoscopy for rapid sequence intubation in an emergency department: A randomised clinical trial. Eur J Anaesthesiol. 2016 Dec;33(12):943-948. doi: 10.1097/EJA.0000000000000525.

    PubMed 27533711

Questions about this trial

What is this clinical trial studying?

A study testing Macintosh blade and C-MAC videolaryngoscope in people with Emergency, run by University of Zurich at 1 site in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Mar 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Success Rate (time frame: 10 minutes). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02297113, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Mar 2016.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in